Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study.

Laura E. Dichtel,Linda L. Carpenter,Maren Nyer,David Mischoulon,Allison Kimball,Thilo Deckersbach,Darin D. Dougherty,David A. Schoenfeld,Lauren B. Fisher,Cristina Cusin,Christina Dording,Nhi-Ha Trinh,Paola Pedrelli,Albert Yeung,Amy Farabaugh,George I. Papakostas,Trina E. Chang,Benjamin G. Shapero,Justin A. Chen,Paolo Cassano,Emily Hahn,Elizabeth M Rao,Roscoe Brady,Ravinder J. Singh,Audrey R. Tyrka,Lawrence H. Price,Maurizio Fava,Karen K. Miller

Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study.

2020

Objective:Low-dose testosterone has been shown to improve depression symptom severity, fatigue, and sexual function in small studies in women not formally diagnosed with major depressive disorder. ...

Keywords:

Sexual function
low dose
Antidepressant
Psychology
Testosterone
Internal medicine
symptom severity
Placebo-controlled study
Placebo
Major depressive disorder
Psychiatry

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations